Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant—review article

2 May 2023

Abstract excerpt

Philadelphia chromosome-like (Ph-like) ALL is a recent subtype of acute lymphoblastic leukemia. Although it does not express the BCR-ABL fusion gene, it has a behavior like true BCR/ABL1-positive cases. This subtype harbors different molecular alterations most commonly CRLF2 rearrangements. Most cases of Ph-like ALL are associated with high white blood cell count, high minimal residual disease level after...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Acute Myeloid Leukemia Research
Share to Chronic Myeloid Leukemia Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37129698
DOI: 10.1007/s00277-023-05241-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 18 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant—review articlePMID 37129698Read ↗

Integrative Insights into Philadelphia-like B-Cell Acute Lymphoblastic Leukemia: A Genetic and Molecular LandscapeSemantic proximity Read ↗

Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.Semantic proximity Read ↗

The biology of Philadelphia chromosome-like ALL.Semantic proximity Read ↗

Philadelphia chromosome–like acute lymphoblastic leukemiaSemantic proximity Read ↗

Philadelphia chromosome-like acute lymphoblastic leukemia: progress in a new cancer subtype.Semantic proximity Read ↗

Philadelphia Chromosome-like Acute Lymphoblastic Leukemia.Semantic proximity Read ↗

Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemiaSemantic proximity Read ↗

The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.Semantic proximity Read ↗

How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemiaSemantic proximity Read ↗

How I treat Philadelphia chromosome–like acute lymphoblastic leukemia in children, adolescents, and young adultsSemantic proximity Read ↗

Philadelphia chromosome-like acute lymphoblastic leukemia. Still a pending matterSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.